Consultant in Public Health, The NHS Screening Programmes, Honorary Senior Lecturer, University of Bristol School of Community and Social Medicine, Bristol, UK.
UK National Screening Committee 1996-2007, Founding Director, The Oxford Centre for Triple Value Healthcare, Oxford, UK.
J Clin Epidemiol. 2020 Jun;122:A8-A13. doi: 10.1016/j.jclinepi.2020.04.008.
This article examines a cervical screening incident from the 1960s and draws lessons for screening policy.
Concern about harmful overtreatment of symptomless lesions prompted university gynecologist Herbert Green to study, between 1965 and 1970, a 'special series' of 33 women with carcinoma in situ (CIS) who were managed with only limited punch or wedge biopsy. These women were carefully followed up but not treated unless they showed evidence of progression to invasive cancer. This paper examines source documents and subsequent publications in order to ascertain lessons from this incident.
In keeping with the 1964 Helsinki Declaration, written consent was not sought. Green published the outcomes for his patients with CIS including the 'special series.' A Judicial inquiry (the Cartwright Inquiry) in 1987 concluded that some women had suffered harm and some had died, but numbers and evidence were not clearly stated. Medical case review for the Inquiry identified 25 women with only punch or wedge biopsy; in 21 of these, there were reasons why no further treatment was given; two had developed cervical cancer, and none were recorded as having died. The case review found eight patients, not necessarily in the 'special series,' who 'in retrospect and by 1987 standards' might have benefited from earlier conisation or hysterectomy.
Subsequent claims relating to Green's practice have wrongly stated that as many as one hundred women or more had treatment withheld and over 30 died as a result. These claims are inaccurate.
本文考察了 20 世纪 60 年代的一次宫颈筛查事件,并从中汲取了有关筛查政策的教训。
由于担心对无症状病变进行过度治疗会带来危害,大学妇科医生赫伯特·格林(Herbert Green)于 1965 年至 1970 年间研究了一组 33 名原位癌(CIS)患者的“特殊系列”,这些患者仅接受了有限的打孔或楔形活检。这些患者得到了仔细的随访,但除非出现进展为浸润性癌的证据,否则不会进行治疗。本文通过查阅原始资料和后续出版物,以确定从该事件中吸取的教训。
根据 1964 年《赫尔辛基宣言》,未征求书面同意。格林发表了他的 CIS 患者的结果,包括“特殊系列”。1987 年的一项司法调查(Cartwright 调查)得出结论,一些女性受到了伤害,一些女性已经死亡,但没有明确说明数字和证据。调查的医疗案例审查确定了仅接受打孔或楔形活检的 25 名女性;在这 25 名女性中,有 21 名女性有理由不进行进一步治疗;有两名女性发展为宫颈癌,没有记录到死亡病例。案例审查发现了 8 名患者,不一定在“特殊系列”中,“回顾过去和 1987 年的标准”,他们可能从早期的子宫颈锥形切除术或子宫切除术受益。
随后与格林实践相关的主张错误地声称多达一百名或更多的女性被拒绝治疗,超过 30 人因此死亡。这些说法是不准确的。